Genscript Biotech Financial Overview
Genscript Biotech's market cap is currently $3.67B. The company's EPS TTM is $-0.022; its P/E ratio is -25.36; Genscript Biotech is scheduled to report earnings on August 17, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
